Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 15 Sept 2026 for Travere Therapeutics, Inc., €2.3M.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Elizabeth Reed: trading record in brief
Our data holds just one disclosure by Elizabeth Reed, dated 15 September 2026, reporting a transaction worth €2.3M in Travere Therapeutics, Inc. Further filings will be added here. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Elizabeth Reed
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 39,576 shares@ US$65.79CommonSEC144:0001950047-26-009520
1 of 1 declaration
